First Horizon Advisors Inc. reduced its stake in shares of Teradyne, Inc. (NASDAQ:TER – Free Report) by 58.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 712 shares of the company’s stock after selling 987 shares during the quarter. First Horizon Advisors Inc.’s holdings in Teradyne were worth $77,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cornerstone Planning Group LLC purchased a new stake in shares of Teradyne during the third quarter worth about $26,000. Annis Gardner Whiting Capital Advisors LLC acquired a new position in shares of Teradyne in the 3rd quarter valued at approximately $27,000. CVA Family Office LLC purchased a new position in shares of Teradyne during the 4th quarter valued at approximately $33,000. Cambridge Trust Co. acquired a new stake in shares of Teradyne during the fourth quarter worth approximately $38,000. Finally, Venturi Wealth Management LLC bought a new stake in shares of Teradyne in the third quarter worth $36,000. 99.77% of the stock is owned by institutional investors and hedge funds.
Teradyne Stock Performance
TER stock opened at $121.09 on Wednesday. The stock’s fifty day moving average is $107.65 and its two-hundred day moving average is $101.48. The stock has a market capitalization of $18.52 billion, a price-to-earnings ratio of 46.04 and a beta of 1.50. Teradyne, Inc. has a 1 year low of $81.07 and a 1 year high of $123.65.
Analyst Upgrades and Downgrades
A number of research analysts have commented on the stock. Susquehanna increased their price objective on shares of Teradyne from $125.00 to $130.00 and gave the company a “positive” rating in a research note on Friday, April 26th. Evercore ISI began coverage on Teradyne in a research note on Tuesday, April 16th. They issued an “outperform” rating and a $130.00 price target for the company. Robert W. Baird increased their target price on Teradyne from $110.00 to $120.00 and gave the stock an “outperform” rating in a report on Friday, April 26th. The Goldman Sachs Group boosted their price target on Teradyne from $107.00 to $118.00 and gave the company a “neutral” rating in a report on Friday, April 26th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $110.00 price objective on shares of Teradyne in a research note on Thursday, April 25th. One research analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $117.83.
View Our Latest Stock Analysis on Teradyne
Insider Buying and Selling
In other Teradyne news, CFO Sanjay Mehta sold 3,750 shares of the business’s stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $120.06, for a total transaction of $450,225.00. Following the completion of the transaction, the chief financial officer now owns 41,902 shares in the company, valued at approximately $5,030,754.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.18% of the company’s stock.
Teradyne Profile
Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
Featured Stories
- Five stocks we like better than Teradyne
- What is the Nikkei 225 index?
- Garmin Navigates to New Highs Driven By Wearables Trend
- How to Effectively Use the MarketBeat Ratings Screener
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- 3 Warren Buffett Stocks to Buy Now
- AbbVie Tracking for New Highs in 2024
Want to see what other hedge funds are holding TER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teradyne, Inc. (NASDAQ:TER – Free Report).
Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.